ORGO logo

ORGO
Organogenesis Holdings Inc - Ordinary Shares - Class A

3,268
Mkt Cap
$306.16M
Volume
831,435.00
52W High
$7.08
52W Low
$2.21
PE Ratio
21.74
ORGO Fundamentals
Price
$2.43
Prev Close
$2.38
Open
$2.40
50D MA
$3.05
Beta
1.90
Avg. Volume
698,170.27
EPS (Annual)
$0.1537
P/B
1.01
Rev/Employee
$660,619.44
$796.28
Loading...
Loading...
News
all
press releases
ORGO Stock Rallies After Hours On Clearing Regulatory Pathway For Pain Relief Treatment
Organogenesis is seeking approval for ReNu in knee osteoarthritis pain, a degenerative joint disease that is estimated to affect nearly 31.1 million Americans.
Stocktwits·8d ago
News Placeholder
More News
News Placeholder
Organogenesis (NASDAQ:ORGO) Receives "Buy" Rating from BTIG Research
BTIG Research reissued a "buy" rating and issued a $8.00 price objective on shares of Organogenesis in a research report on Thursday...
MarketBeat·19d ago
News Placeholder
Assenagon Asset Management S.A. Acquires 680,392 Shares of Organogenesis $ORGO
Assenagon Asset Management S.A. raised its stake in shares of Organogenesis (NASDAQ:ORGO - Free Report) by 14.0% during the fourth quarter, according to its most recent disclosure with the Securities...
MarketBeat·19d ago
News Placeholder
Organogenesis $ORGO Shares Acquired by First Light Asset Management LLC
First Light Asset Management LLC lifted its stake in shares of Organogenesis (NASDAQ:ORGO - Free Report) by 10.6% during the 3rd quarter, according to the company in its most recent filing with the...
MarketBeat·29d ago
News Placeholder
Insider Buying: Organogenesis (NASDAQ:ORGO) Director Buys 5,000 Shares of Stock
Organogenesis (NASDAQ:ORGO - Get Free Report) Director Arthur Leibowitz purchased 5,000 shares of the stock in a transaction on Monday, March 9th. The stock was acquired at an average cost of $2.68...
MarketBeat·1mo ago
News Placeholder
Michael Joseph Driscoll Buys 10,000 Shares of Organogenesis (NASDAQ:ORGO) Stock
Organogenesis (NASDAQ:ORGO - Get Free Report) Director Michael Joseph Driscoll purchased 10,000 shares of the business's stock in a transaction on Monday, March 9th. The shares were purchased at an...
MarketBeat·1mo ago
News Placeholder
Insider Buying: Organogenesis (NASDAQ:ORGO) Director Buys $13,400.00 in Stock
Organogenesis (NASDAQ:ORGO - Get Free Report) Director Arthur Leibowitz acquired 5,000 shares of the firm's stock in a transaction on Monday, March 9th. The shares were acquired at an average price...
MarketBeat·1mo ago
News Placeholder
Organogenesis (NASDAQ:ORGO) Director Michael Joseph Driscoll Purchases 10,000 Shares of Stock
Organogenesis (NASDAQ:ORGO - Get Free Report) Director Michael Joseph Driscoll bought 10,000 shares of the firm's stock in a transaction dated Monday, March 9th. The stock was purchased at an average...
MarketBeat·1mo ago
News Placeholder
Organogenesis (NASDAQ:ORGO) Upgraded by Wall Street Zen to "Buy" Rating
Wall Street Zen upgraded shares of Organogenesis from a "hold" rating to a "buy" rating in a report on Sunday...
MarketBeat·1mo ago
News Placeholder
Wall Street Zen Downgrades Organogenesis (NASDAQ:ORGO) to Hold
Wall Street Zen downgraded Organogenesis from a "strong-buy" rating to a "hold" rating in a report on Saturday...
MarketBeat·2mo ago
<
1
2
...
>

Latest ORGO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.